FluMist approved for self-administration in the US - astrazeneca.com
WEB20 hours ago · FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from …
FDA approves first flu vaccine that can be self-administered at …
WEB17 hours ago · Link Copied! The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. The US Food and Drug Administration on Friday approved the first ...
FLUMIST approved for self-administration in the US
WEB17 hours ago · Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said: “The approval of FLUMIST for self-administration is an important step forward in making vaccines more ...
FDA approves ‘FluMist,' says no healthcare provider needed
WEB1 day ago · The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first vaccine to ...
FDA approves first self-administered flu vaccine spray - CBS News
WEB17 hours ago · The FDA approved AstraZeneca's FluMist flu vaccine spray for self-administered use at home. ... Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the ...
US FDA approves AstraZeneca's flu vaccine for self-administration
WEB21 hours ago · Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L), opens new tab nasal spray flu vaccine for self-administration, making it the first ...
FDA approves first at-home flu vaccine in U.S., a nasal spray
WEB19 hours ago · Sept. 20, 2024. Senior Writer, Infectious Diseases. The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home ...
US Food and Drug Administration accepts for review AstraZeneca…
WEBOct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA).
FLUMIST® QUADRIVALENT (Influenza Vaccine Live ... - AstraZeneca US
WEBSep 23, 2022 · AstraZeneca announces FLUMIST ® QUADRIVALENT (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2022-2023 influenza season. FLUMIST QUADRIVALENT, the only Food and Drug Administration (FDA)-approved nasal-spray flu vaccine, is indicated for people ages 2 through 49. 1.
FDA approves at-home FluMist administration | CIDRAP
WEB19 hours ago · The Food and Drug Administration (FDA) today announced that it has approved self- or caregiver-administered FluMist, making it the first flu vaccine that doesn’t have to be administered by a healthcare provider. In a statement, the FDA said that MedImmune, the maker of FluMist, plans to offer the …
Skip to content